Ozempic vs Mounjaro
Ozempic and Mounjaro are the two weekly injections approved for type 2 diabetes, and they use different active ingredients: semaglutide in Ozempic, tirzepatide in Mounjaro. This page compares them on the things that actually differ: how each works, how the dose schedules are shaped, what the trial programs behind the ingredients found, the side effect profiles, and the monthly list price of each. It does not crown a winner, because for diabetes the right pen depends on your blood sugar goals, your history and your prescriber.
The two diabetes pens at a glance
| Detail | Ozempic | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide, a GLP-1 receptor agonist | Tirzepatide, which acts on both GIP and GLP-1 receptors |
| Approved for | Type 2 diabetes | Type 2 diabetes |
| How often | One injection, once a week | One injection, once a week |
| Max weekly dose | 2 mg | 15 mg |
| Trial result (ingredient level) | Semaglutide at 2.4 mg averaged 14.9 percent weight loss over 68 weeks in STEP 1 | Tirzepatide at 15 mg averaged 20.9 percent weight loss over 72 weeks in SURMOUNT-1 |
| About list price per month | About $1,000 | About $1,080 |
Read the trial row with care. STEP 1 and SURMOUNT-1 studied these ingredients at their weight management doses, in separate trials with different groups of people over different lengths of time. They were not a head to head comparison, and both medicines on this page earned their diabetes approvals in blood sugar trials, not weight trials.
How they differ in practice
Mechanism is the first difference. Ozempic's ingredient, semaglutide, acts on the GLP-1 receptor alone. Mounjaro's ingredient, tirzepatide, acts on two receptors, GIP and GLP-1. Both slow stomach emptying, reduce appetite and support insulin release when blood sugar is high, and both are taken as one injection once a week.
The dose ranges look wildly different, 2 mg against 15 mg, but the numbers are not comparable across molecules. Each schedule starts low: Ozempic at 0.25 mg with optional steps up to 2 mg, Mounjaro at 2.5 mg with 2.5 mg steps up to 15 mg, always with at least four weeks between increases. The Ozempic dosage chart and the Mounjaro dosage chart show both in full, and the semaglutide vs tirzepatide page compares the ingredients behind them.
Side effects compared
Both labels are led by the same gastrointestinal effects: nausea, vomiting, diarrhea and constipation, usually worst while the dose is climbing. Neither label supports a simple claim that one is gentler than the other for everyone, because responses are individual and dose dependent. The Ozempic side effects page and the Mounjaro side effects page set out each profile, including the serious warnings.
Who each is usually prescribed for
Both products carry the same label: type 2 diabetes. That makes this a genuine either or decision for prescribers, who weigh how much blood sugar control is needed, whether weight is also a treatment goal, how a person handled any earlier medicine, and what their insurance covers. There is no label rule that assigns one pen to one kind of patient, which is exactly why this page does not declare a winner: the deciding factors are personal and clinical.
Switching between them
Switching between Ozempic and Mounjaro is common in diabetes care, usually because blood sugar targets are not being met, side effects are limiting the dose, or coverage changes. It is always a prescriber decision, never a self switch. The milligram numbers do not convert across, so your prescriber will choose where you start on the new schedule and how the changeover is timed. Do not overlap the two medicines while changing over unless your prescriber specifically tells you to.
Frequently asked questions
Is Mounjaro better than Ozempic for diabetes?
This page cannot answer that for you, and no honest page can. Both medicines were approved on their own diabetes trial programs, and the headline weight figures for the two ingredients come from separate weight trials, not a head to head study. Prescribers weigh your blood sugar results, weight, tolerability and coverage, which is why the choice is made in the clinic, not on a comparison page.
Why do the doses look so different, 2 mg against 15 mg?
Because they are different molecules. A milligram of semaglutide and a milligram of tirzepatide are not the same amount of effect, so the schedules were each built around their own ingredient. Ozempic runs from 0.25 mg to a 2 mg maximum; Mounjaro runs from 2.5 mg to 15 mg. Never convert a dose from one to the other yourself.
Which costs more, Ozempic or Mounjaro?
Mounjaro, slightly, at list price: about $1,080 a month against about $1,000 for Ozempic. The gap is small next to the effect of insurance coverage, so what you actually pay will depend on your plan's rules for each product.
Can I switch from Ozempic to Mounjaro?
Yes, switching is common, but it is a prescriber decision, never a self switch. Your prescriber will pick the starting dose on the Mounjaro schedule, since the doses do not convert, and will time the changeover. Do not take both in the same week unless your prescriber specifically instructs it.
Do Ozempic and Mounjaro have the same side effects?
The profiles overlap a lot. Both labels list nausea, vomiting, diarrhea and constipation among the most common effects, especially while doses rise. Which one a given person tolerates better cannot be predicted from the labels; the Ozempic side effects and Mounjaro side effects pages on this site cover each in detail.